| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |